129 related articles for article (PubMed ID: 22378275)
1. Estrogen receptor β transcript variants associate with oncogene expression in endometrial cancer.
Häring J; Skrzypczak M; Stegerer A; Lattrich C; Weber F; Görse R; Ortmann O; Treeck O
Int J Mol Med; 2012 Jun; 29(6):1127-36. PubMed ID: 22378275
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of mRNA expression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium.
Skrzypczak M; Bieche I; Szymczak S; Tozlu S; Lewandowski S; Girault I; Radwanska K; Szczylik C; Jakowicki JA; Lidereau R; Kaczmarek L
Int J Cancer; 2004 Jul; 110(6):783-7. PubMed ID: 15170658
[TBL] [Abstract][Full Text] [Related]
4. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of estrogen receptor α and progesterone receptor transcript variants in endometrial cancer.
Skrzypczak M; Merx I; Schüler-Toprak S; Weber F; Inwald EC; Ortmann O; Treeck O
Steroids; 2015 Dec; 104():122-8. PubMed ID: 26428028
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.
Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S
Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
8. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors.
Wimberly H; Han G; Pinnaduwage D; Murphy LC; Yang XR; Andrulis IL; Sherman M; Figueroa J; Rimm DL
Breast Cancer Res Treat; 2014 Aug; 146(3):657-67. PubMed ID: 25007965
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT1 is overexpressed in endometrial cancer and regulates growth and transcriptome of endometrial adenocarcinoma cells.
Treeck O; Skrzypczak M; Schüler-Toprak S; Weber F; Ortmann O
Int J Biochem Cell Biol; 2020 May; 122():105740. PubMed ID: 32173521
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.
Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma.
Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S
Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672
[TBL] [Abstract][Full Text] [Related]
13. [Association between the expression of estrogen receptor subunit in endometrial carcinoma and the prognostic factors of endometrial carcinoma].
Zhang JW; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):843-5. PubMed ID: 15573770
[TBL] [Abstract][Full Text] [Related]
14. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
15. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
16. The ERβ5 splice variant increases oestrogen responsiveness of ERαpos Ishikawa cells.
Collins F; Itani N; Esnal-Zufiaurre A; Gibson DA; Fitzgerald C; Saunders PTK
Endocr Relat Cancer; 2020 Feb; 27(2):55-66. PubMed ID: 31778358
[TBL] [Abstract][Full Text] [Related]
17. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
[TBL] [Abstract][Full Text] [Related]
18. Elevated oestrogen receptor splice variant ERαΔ5 expression in tumour-adjacent hormone-responsive tissue.
Taylor SE; Patel II; Singh PB; Nicholson CM; Stringfellow HF; Gopala Krishna RK; Matanhelia SS; Martin-Hirsch PL; Martin FL
Int J Environ Res Public Health; 2010 Nov; 7(11):3871-89. PubMed ID: 21139866
[TBL] [Abstract][Full Text] [Related]
19. Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN.
Skrzypczak M; Lattrich C; Häring J; Schüler S; Ortmann O; Treeck O
Gynecol Endocrinol; 2013 Dec; 29(12):1031-5. PubMed ID: 24053619
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
